Clinical implication of minimal presence of solid or micropapillary subtype in early ‐stage lung adenocarcinoma
ConclusionsThe presence of the minimal S/MP component was a significant predictor of poor prognosis after surgery, even in stage IA patients. Clinical trials to evaluate the advantages of adjuvant chemotherapy for this subset of patients and further investigations to understand underlying biological mechanisms of poor prognosis are needed.Key pointsSignificant findings of the study: We demonstrated that only minimal presence of solid or micropapillary component was profoundly associated with aggressive clinicopathological features and poor prognosis after complete resection even in stage IA lung adenocarcinoma. What this study adds: Our results suggest that minimal presence of these subtypes is a strong prognostic factor which should be taken into account in the risk assessment for adjuvant chemotherapy in lung adenocarcinoma.
Source: Thoracic Cancer - Category: Cancer & Oncology Authors: Sun Ha Choi,
Ji Yun Jeong,
Shin Yup Lee,
Kyung Min Shin,
Shin Young Jeong,
Tae ‐In Park,
Young Woo Do,
Eung Bae Lee,
Yangki Seok,
Won Kee Lee,
Ji Eun Park,
Sunji Park,
Yong Hoon Lee,
Hyewon Seo,
Seung Soo Yoo,
Jaehee Lee,
Seung‐Ick Cha Tags: ORIGINAL ARTICLE Source Type: research
More News: Adenocarcinoma | Cancer | Cancer & Oncology | Cardiovascular & Thoracic Surgery | Chemotherapy | Clinical Trials | Micropapillary Carcinoma | Study